Detalhe da pesquisa
1.
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?
Ann Rheum Dis
; 83(1): 65-71, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607810
2.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
3.
Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis.
Rheumatology (Oxford)
; 63(3): 594-607, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725352
4.
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Cell Commun Signal
; 22(1): 94, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308278
5.
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 82(4): 468-475, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526336
6.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410794
7.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 107-118, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376026
8.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368906
9.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
10.
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
J Autoimmun
; 135: 102988, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634459
11.
Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act!
Rheumatology (Oxford)
; 62(SI3): SI274-SI281, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871921
12.
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation.
Rheumatology (Oxford)
; 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127964
13.
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Lancet
; 397(10271): 305-317, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485455
14.
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response.
Ann Rheum Dis
; 81(10): 1385-1391, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725296
15.
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 81(7): 937-943, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470162
16.
Standardisation of ACPA tests: evaluation of a new candidate reference preparation.
Ann Rheum Dis
; 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697487
17.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376
18.
New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis.
Rheumatology (Oxford)
; 62(1): 108-115, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416951
19.
IgA rheumatoid factor in rheumatoid arthritis.
Clin Chem Lab Med
; 60(10): 1617-1626, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790193
20.
TET2-Driver and NLRC4-Passenger Variants in Adult-Onset Autoinflammation.
N Engl J Med
; 388(17): 1626-1629, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099347